The Clinical Development Team at Aeglea BioTherapeutics is responsible for designing and overseeing clinical trials that evaluate the safety and efficacy of innovative enzyme therapeutics for rare metabolic diseases. This multidisciplinary team collaborates on the development of study protocols, manages clinical data collection and analysis, and ensures compliance with regulatory standards, ultimately driving the progression of groundbreaking therapies from concept to reality.
View all